Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Thrombosis Research|September 25, 2014
Underestimation of unfractionated heparin therapy assessment due to platelet activation when using partial-draw (pediatric) citrate collection tubesCéline Desconclois, Valérie Eschwège, Valérie Proulle, et al.
European Journal of Haematology|July 16, 2020
Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals)Christophe Nougier, Emmanuelle Jeanpierre, Catherine Ternisien, et al.
Journal of Pediatric Hematology/Oncology|July 9, 2003
Misdiagnosis of chronic thrombocytopenia in childhoodBrigitte Bader-Meunier, Valérie Proulle, Catherine Trichet, et al.
British Journal of Haematology|November 12, 2005
Circulating microparticles are elevated in haemophiliacs and non-haemophilic individuals aged <18 yearsValérie Proulle, Bénédicte Hugel, Benoit Guillet, et al.
Thrombosis and Haemostasis|April 30, 2004
Injection of recombinant activated factor VII can induce transient increase in circulating procoagulant microparticlesValérie Proulle, Bénédicte Hugel, Benoit Guillet, et al.
British Journal of Haematology|February 18, 2003
Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacityLysiane Hilbert, Sylvie Jorieux, Valérie Proulle, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 24, 2017
A Novel Single-Domain Antibody Against von Willebrand Factor A1 Domain Resolves Leukocyte Recruitment and Vascular Leakage During Inflammation-Brief ReportGabriel Aymé, Frédéric Adam, Paulette Legendre, et al.
Frontiers in Medicine|June 17, 2021
A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC FilterCarine Farkh, Syrine Ellouze, Louis Gounelle, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 24, 2020
Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosisDong Wang, Yongshuai Yang, Yu Wang, et al.
Haematologica|January 19, 2023
The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A miceMelissa Bou-Jaoudeh, Sandrine Delignat, Victoria Daventure, et al.
Pageof 4